PlainPharmaWatch

CMS Open Payments · Program Year 2024

Alafair Biosciences, Inc.

Alafair Biosciences, Inc. reported $10,781,868.25 in payments to 704 physicians and teaching hospitals across 732 transactions.

See the rankings → How this is sourced
$10.8M
Total payments
732
Transactions
704
Recipients
+$61.7K
General Payments vs PY2023

Alafair Biosciences, Inc. reported $10,781,868.25 in payments to 704 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #160 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $15.3K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Alafair Biosciences, Inc. pairs top-10% payment volume with a moderately concentrated payment pattern.

#160
of 1,925 companies
0.1%
of all US industry payments
0.5%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Alafair Biosciences, Inc.'s CMS-reported General Payments increased by $61.7K (+36.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ALAFAIR BIOSCIENCES, INC.PY2023: ALAFAIR BIOSCIENCES, INC.PY2024: Alafair Biosciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$170.0KPY2024$231.7K
PY2023
$170,030.46
PY2024
$231,706.25

How Alafair Biosciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Alafair Biosciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$10,781,868 Top 8% higher than 92% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Alafair Biosciences, Inc.

In Program Year 2024, Alafair Biosciences, Inc. reported $10,781,868.25 in payments to 704 physicians and teaching hospitals across 732 individual transactions, an average of $14.7K per transaction and $15.3K per recipient. That total places Alafair Biosciences, Inc. at rank #160 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.1% slice of all industry payments reported nationwide for the year.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $125.0K, accounting for 1.2% of the company's reported total and 13 transactions.

General Payment Breakdown by Type

"Consulting Fee" leads Alafair Biosciences, Inc.'s 4-category general-payment breakdown at $125.0K, 1.2% of the reported total.

How Alafair Biosciences, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$125.0K2. Food and Beverage$59.9K3. Compensation for Services…$33.8K4. Travel and Lodging$13.0K
Payment Type Amount Transactions
Consulting Fee $125.0K 13
Food and Beverage $59.9K 639
Compensation for Services Other Than Consulting $33.8K 20
Travel and Lodging $13.0K 32

Recipient Concentration in General Payments

The five largest recipient relationships account for $156,541.32 (67.6%) of $231,706.25 in this company's General Payments records across 452 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Alafair Biosciences, Inc.

The five named recipients with the highest reported General Payments from this company

Daniel Peterson$122.3KEric Giza$13.0KBauback Safa$11.0KWalter Lin$5.9KRobert Johnson$4.3K
  1. 1

    Daniel Peterson

    $122,267.12 across 46 reported transactions

  2. 2

    Eric Giza

    $13,037.45 across 10 reported transactions

  3. 3

    Bauback Safa

    $11,046.09 across 10 reported transactions

  4. 4

    Walter Lin

    $5,929.53 across 13 reported transactions

  5. 5

    Robert Johnson

    $4,261.13 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $14.7K. Average per recipient: $15.3K.

Total Amount

$10,781,868.25

Avg per Transaction

$14.7K

Avg per Recipient

$15.3K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Alafair Biosciences, Inc. Share

0.1%

#160 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Alafair Biosciences, Inc.

Glaukos Corporation

$10.8M 11,456 recipients

Mesh Suture Inc

$10.8M 86 recipients

TG Therapeutics, Inc.

$10.7M 12,185 recipients

Ortho-Clinical Diagnostics, Inc.

$10.7M 232 recipients

Sanofi-Aventis U.s. LLC

$10.7M 42,061 recipients

Lexicon Pharmaceuticals, Inc.

$10.7M 20,498 recipients

Frequently Asked Questions

How much did Alafair Biosciences, Inc. pay to physicians and hospitals in 2024? ▾
Alafair Biosciences, Inc. made $10,781,868.25 in payments to physicians and hospitals in Program Year 2024, across 732 individual transactions. This represents 0.1% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Alafair Biosciences, Inc.? ▾
Alafair Biosciences, Inc. made payments to 704 physicians and teaching hospitals in 2024. The average payment per recipient was $15.3K.
What types of payments did Alafair Biosciences, Inc. make? ▾
Alafair Biosciences, Inc. made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $125.0K, representing 1.2% of the company's reported total.
How does Alafair Biosciences, Inc. rank among pharmaceutical companies? ▾
Alafair Biosciences, Inc. ranks #160 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Alafair Biosciences, Inc.? ▾
The average transaction from Alafair Biosciences, Inc. was $14.7K in 2024. The company made 732 total transactions to 704 recipients.
Where does the payment data for Alafair Biosciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Alafair Biosciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.